Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Single-Cell Virus Sequencing of Influenza Infections That Trigger Innate Immunity.

Russell AB, Elshina E, Kowalsky JR, Te Velthuis AJW, Bloom JD.

J Virol. 2019 Jun 28;93(14). pii: e00500-19. doi: 10.1128/JVI.00500-19. Print 2019 Jul 15.

2.

Extreme heterogeneity of influenza virus infection in single cells.

Russell AB, Trapnell C, Bloom JD.

Elife. 2018 Feb 16;7. pii: e32303. doi: 10.7554/eLife.32303.

3.

Neonatal listeriosis in the UK 2004-2014.

Sapuan S, Kortsalioudaki C, Anthony M, Chang J, Embleton ND, Geethanath RM, Gray J, Greenough A, Lal MK, Luck S, Pattnayak S, Reynolds P, Russell AB, Scorrer T, Turner M, Heath PT, Vergnano S.

J Infect. 2017 Mar;74(3):236-242. doi: 10.1016/j.jinf.2016.11.007. Epub 2016 Nov 17.

PMID:
27867063
4.

ASSESSMENT OF VANCOMYCIN CONCENTRATIONS IN SYRINGES PREPARED WITHIN A WARD SETTING.

Saimbi S, Batchelor H, Whitticase L, Holder G, Russell AB.

Arch Dis Child. 2016 Sep;101(9):e2. doi: 10.1136/archdischild-2016-311535.18.

PMID:
27540196
5.

Human symbionts inject and neutralize antibacterial toxins to persist in the gut.

Wexler AG, Bao Y, Whitney JC, Bobay LM, Xavier JB, Schofield WB, Barry NA, Russell AB, Tran BQ, Goo YA, Goodlett DR, Ochman H, Mougous JD, Goodman AL.

Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3639-44. doi: 10.1073/pnas.1525637113. Epub 2016 Mar 8.

6.

Kin cell lysis is a danger signal that activates antibacterial pathways of Pseudomonas aeruginosa.

LeRoux M, Kirkpatrick RL, Montauti EI, Tran BQ, Peterson SB, Harding BN, Whitney JC, Russell AB, Traxler B, Goo YA, Goodlett DR, Wiggins PA, Mougous JD.

Elife. 2015 Feb 2;4. doi: 10.7554/eLife.05701.

7.

A type VI secretion-related pathway in Bacteroidetes mediates interbacterial antagonism.

Russell AB, Wexler AG, Harding BN, Whitney JC, Bohn AJ, Goo YA, Tran BQ, Barry NA, Zheng H, Peterson SB, Chou S, Gonen T, Goodlett DR, Goodman AL, Mougous JD.

Cell Host Microbe. 2014 Aug 13;16(2):227-236. doi: 10.1016/j.chom.2014.07.007. Epub 2014 Jul 25.

8.

Genetically distinct pathways guide effector export through the type VI secretion system.

Whitney JC, Beck CM, Goo YA, Russell AB, Harding BN, De Leon JA, Cunningham DA, Tran BQ, Low DA, Goodlett DR, Hayes CS, Mougous JD.

Mol Microbiol. 2014 May;92(3):529-42. doi: 10.1111/mmi.12571. Epub 2014 Mar 28.

9.

Type VI secretion system effectors: poisons with a purpose.

Russell AB, Peterson SB, Mougous JD.

Nat Rev Microbiol. 2014 Feb;12(2):137-48. doi: 10.1038/nrmicro3185. Epub 2014 Jan 2. Review.

10.

Identification, structure, and function of a novel type VI secretion peptidoglycan glycoside hydrolase effector-immunity pair.

Whitney JC, Chou S, Russell AB, Biboy J, Gardiner TE, Ferrin MA, Brittnacher M, Vollmer W, Mougous JD.

J Biol Chem. 2013 Sep 13;288(37):26616-24. doi: 10.1074/jbc.M113.488320. Epub 2013 Jul 22.

11.

Diverse type VI secretion phospholipases are functionally plastic antibacterial effectors.

Russell AB, LeRoux M, Hathazi K, Agnello DM, Ishikawa T, Wiggins PA, Wai SN, Mougous JD.

Nature. 2013 Apr 25;496(7446):508-12. doi: 10.1038/nature12074. Epub 2013 Apr 3.

12.

Quantitative single-cell characterization of bacterial interactions reveals type VI secretion is a double-edged sword.

LeRoux M, De Leon JA, Kuwada NJ, Russell AB, Pinto-Santini D, Hood RD, Agnello DM, Robertson SM, Wiggins PA, Mougous JD.

Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19804-9. doi: 10.1073/pnas.1213963109. Epub 2012 Nov 12.

13.

Pseudomonas syringae pv. tomato DC3000 CmaL (PSPTO4723), a DUF1330 family member, is needed to produce L-allo-isoleucine, a precursor for the phytotoxin coronatine.

Worley JN, Russell AB, Wexler AG, Bronstein PA, Kvitko BH, Krasnoff SB, Munkvold KR, Swingle B, Gibson DM, Collmer A.

J Bacteriol. 2013 Jan;195(2):287-96. doi: 10.1128/JB.01352-12. Epub 2012 Nov 9.

14.

Structure of a peptidoglycan amidase effector targeted to Gram-negative bacteria by the type VI secretion system.

Chou S, Bui NK, Russell AB, Lexa KW, Gardiner TE, LeRoux M, Vollmer W, Mougous JD.

Cell Rep. 2012 Jun 28;1(6):656-64. doi: 10.1016/j.celrep.2012.05.016. Epub 2012 May 31.

15.

A widespread bacterial type VI secretion effector superfamily identified using a heuristic approach.

Russell AB, Singh P, Brittnacher M, Bui NK, Hood RD, Carl MA, Agnello DM, Schwarz S, Goodlett DR, Vollmer W, Mougous JD.

Cell Host Microbe. 2012 May 17;11(5):538-49. doi: 10.1016/j.chom.2012.04.007.

16.

Type VI secretion delivers bacteriolytic effectors to target cells.

Russell AB, Hood RD, Bui NK, LeRoux M, Vollmer W, Mougous JD.

Nature. 2011 Jul 20;475(7356):343-7. doi: 10.1038/nature10244.

17.

Characterisation of HFBII biosurfactant production and foam fractionation with and without antifoaming agents.

Winterburn JB, Russell AB, Martin PJ.

Appl Microbiol Biotechnol. 2011 May;90(3):911-20. doi: 10.1007/s00253-011-3137-2. Epub 2011 Feb 11.

PMID:
21311879
18.

Genetic disassembly and combinatorial reassembly identify a minimal functional repertoire of type III effectors in Pseudomonas syringae.

Cunnac S, Chakravarthy S, Kvitko BH, Russell AB, Martin GB, Collmer A.

Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2975-80. doi: 10.1073/pnas.1013031108. Epub 2011 Jan 31.

19.

Improving antibiotic prescribing in neonatal units: time to act.

Russell AB, Sharland M, Heath PT.

Arch Dis Child Fetal Neonatal Ed. 2012 Mar;97(2):F141-6. doi: 10.1136/adc.2007.120709. Epub 2010 Oct 30. Review.

PMID:
21037285
20.

Neonatal infections in England: the NeonIN surveillance network.

Vergnano S, Menson E, Kennea N, Embleton N, Russell AB, Watts T, Robinson MJ, Collinson A, Heath PT.

Arch Dis Child Fetal Neonatal Ed. 2011 Jan;96(1):F9-F14. doi: 10.1136/adc.2009.178798. Epub 2010 Sep 27.

PMID:
20876594
21.

Pseudomonas syringae pv. tomato DC3000 type III effector HopAA1-1 functions redundantly with chlorosis-promoting factor PSPTO4723 to produce bacterial speck lesions in host tomato.

Munkvold KR, Russell AB, Kvitko BH, Collmer A.

Mol Plant Microbe Interact. 2009 Nov;22(11):1341-55. doi: 10.1094/MPMI-22-11-1341.

22.

Mosaic trisomy 1q: The longest surviving case.

Patel C, Hardy G, Cox P, Bowdin S, McKeown C, Russell AB.

Am J Med Genet A. 2009 Aug;149A(8):1795-800. doi: 10.1002/ajmg.a.32959.

PMID:
19610079
23.

Missed opportunities for preventing group B streptococcus infection.

Vergnano S, Embleton N, Collinson A, Menson E, Russell AB, Heath P.

Arch Dis Child Fetal Neonatal Ed. 2010 Jan;95(1):F72-3. doi: 10.1136/adc.2009.160333. Epub 2009 May 12.

PMID:
19439431
24.

Deletions in the repertoire of Pseudomonas syringae pv. tomato DC3000 type III secretion effector genes reveal functional overlap among effectors.

Kvitko BH, Park DH, Velásquez AC, Wei CF, Russell AB, Martin GB, Schneider DJ, Collmer A.

PLoS Pathog. 2009 Apr;5(4):e1000388. doi: 10.1371/journal.ppat.1000388. Epub 2009 Apr 17.

25.

Surface properties of class ii hydrophobins from Trichoderma reesei and influence on bubble stability.

Cox AR, Cagnol F, Russell AB, Izzard MJ.

Langmuir. 2007 Jul 17;23(15):7995-8002. Epub 2007 Jun 20.

PMID:
17580918
26.

Estimated early-onset group B streptococcal neonatal disease.

Luck S, Torny M, d'Agapeyeff K, Pitt A, Heath P, Breathnach A, Russell AB.

Lancet. 2003 Jun 7;361(9373):1953-4.

PMID:
12801740
27.

Palivizumab: an overview.

Russell AB.

Hosp Med. 1999 Dec;60(12):873-7. Review.

PMID:
10707171
28.

Neurexin is expressed on nerves, but not at nerve terminals, in the electric organ.

Russell AB, Carlson SS.

J Neurosci. 1997 Jun 15;17(12):4734-43.

29.

Aircraft down.

Russell AB.

Wilderness Environ Med. 1996 May;7(2):190-1. No abstract available.

PMID:
11990110
30.

The influence of vessel height and top-section size on the hydrodynamic characteristics of airlift fermentors.

Russell AB, Thomas CR, Lilly MD.

Biotechnol Bioeng. 1994 Jan 5;43(1):69-76.

PMID:
18613312
31.

Post-mortem blood alcohol survey in some Australian states.

Russell AB.

Med J Aust. 1971 Nov 6;2(19):948-51. No abstract available.

PMID:
5117304

Supplemental Content

Loading ...
Support Center